Loading…

Transcatheter Arterial Embolization for Renal Angiomyolipoma Using a Micro-balloon Catheter and a Mixture of Ethanol and Lipiodol

Purpose To evaluate the efficacy and safety of transcatheter arterial embolization (TAE) for renal angiomyolipoma (AML) using a micro-balloon catheter and a mixture of ethanol and lipiodol. Materials and Methods Twelve consecutive patients with 15 AMLs, 9 females and 3 males, with a median age of 44...

Full description

Saved in:
Bibliographic Details
Published in:Cardiovascular and interventional radiology 2017-12, Vol.40 (12), p.1933-1939
Main Authors: Sawada, Yusuke, Shimohira, Masashi, Hashizume, Takuya, Sobue, Ryoji, Mori, Soichiro, Nakagawa, Motoo, Ozawa, Yoshiyuki, Naiki, Taku, Nagai, Takashi, Yasui, Takahiro, Shibamoto, Yuta
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c438t-75f3036e5d4472381d98f95f16018dbc9afd6640524b0f982044dfb094e2243a3
cites cdi_FETCH-LOGICAL-c438t-75f3036e5d4472381d98f95f16018dbc9afd6640524b0f982044dfb094e2243a3
container_end_page 1939
container_issue 12
container_start_page 1933
container_title Cardiovascular and interventional radiology
container_volume 40
creator Sawada, Yusuke
Shimohira, Masashi
Hashizume, Takuya
Sobue, Ryoji
Mori, Soichiro
Nakagawa, Motoo
Ozawa, Yoshiyuki
Naiki, Taku
Nagai, Takashi
Yasui, Takahiro
Shibamoto, Yuta
description Purpose To evaluate the efficacy and safety of transcatheter arterial embolization (TAE) for renal angiomyolipoma (AML) using a micro-balloon catheter and a mixture of ethanol and lipiodol. Materials and Methods Twelve consecutive patients with 15 AMLs, 9 females and 3 males, with a median age of 44 years (range, 11–81), underwent this procedure between 2011 and 2016. In all procedures, a micro-balloon catheter was advanced to the feeding artery of the AML and TAE was performed with a mixture of ethanol and lipiodol under balloon inflation. We reviewed medical records and images, and evaluated the technical success rate, clinical success rate, and complications. Technical success was defined as completion of TAE using the micro-balloon catheter and the mixture of ethanol and lipiodol. Clinical success was defined as reduction of tumor size on CT, which was performed before and after TAE. Results In 14 of 15 AMLs, the micro-balloon catheter could be advanced to the feeding artery, and TAE was performed successfully. Thus, the technical success rate was 93%. Among these 14 AMLs of 11 patients, 13 AMLs of 10 patients could be followed and tumor shrinkage was confirmed in all. Thus, the clinical success rate was 100%. Four patients had mild symptoms after TAE; the minor complication rate was 33% (4/12), and the major complication rate was 0%. Conclusion TAE for renal AML using the micro-balloon catheter and mixture of ethanol and lipiodol appears to be effective and safe.
doi_str_mv 10.1007/s00270-017-1731-0
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1917364300</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1955412306</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-75f3036e5d4472381d98f95f16018dbc9afd6640524b0f982044dfb094e2243a3</originalsourceid><addsrcrecordid>eNp1kU9rFDEYxoModq1-AC8S8OIl-ubfTOa4LOsfWBGkBW8hM5NsUzLJmsyA9dZv3my3FRG8JJDnl1948yD0msJ7CtB-KACsBQK0JbTllMATtKKCMwKq-fEUrWogCJWSnqEXpVwDUKmYfI7OmGqU5G23QrcX2cQymPnKzjbjda6rNwFvpz4F_9vMPkXsUsbfbazH67j3abqp0SFNBl8WH_fY4K9-yIn0JoRU8c2jzcTxPvw1L9ni5PB2vjIxhftg5w8-jSm8RM-cCcW-etjP0eXH7cXmM9l9-_Rls96RQXA1k1Y6DryxchSiZVzRsVOuk442QNXYD51xY9MIkEz04DrFQIjR9dAJy5jghp-jdyfvIaefiy2znnwZbAgm2rQUTbv6h43gABV9-w96nZZc5z9SUgrKODSVoieqzl5Ktk4fsp9MvtEU9LEffepH1xr0sR99NL95MC_9ZMc_Nx4LqQA7AaVGcW_zX0__13oHqFaajg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1955412306</pqid></control><display><type>article</type><title>Transcatheter Arterial Embolization for Renal Angiomyolipoma Using a Micro-balloon Catheter and a Mixture of Ethanol and Lipiodol</title><source>Springer Link</source><creator>Sawada, Yusuke ; Shimohira, Masashi ; Hashizume, Takuya ; Sobue, Ryoji ; Mori, Soichiro ; Nakagawa, Motoo ; Ozawa, Yoshiyuki ; Naiki, Taku ; Nagai, Takashi ; Yasui, Takahiro ; Shibamoto, Yuta</creator><creatorcontrib>Sawada, Yusuke ; Shimohira, Masashi ; Hashizume, Takuya ; Sobue, Ryoji ; Mori, Soichiro ; Nakagawa, Motoo ; Ozawa, Yoshiyuki ; Naiki, Taku ; Nagai, Takashi ; Yasui, Takahiro ; Shibamoto, Yuta</creatorcontrib><description>Purpose To evaluate the efficacy and safety of transcatheter arterial embolization (TAE) for renal angiomyolipoma (AML) using a micro-balloon catheter and a mixture of ethanol and lipiodol. Materials and Methods Twelve consecutive patients with 15 AMLs, 9 females and 3 males, with a median age of 44 years (range, 11–81), underwent this procedure between 2011 and 2016. In all procedures, a micro-balloon catheter was advanced to the feeding artery of the AML and TAE was performed with a mixture of ethanol and lipiodol under balloon inflation. We reviewed medical records and images, and evaluated the technical success rate, clinical success rate, and complications. Technical success was defined as completion of TAE using the micro-balloon catheter and the mixture of ethanol and lipiodol. Clinical success was defined as reduction of tumor size on CT, which was performed before and after TAE. Results In 14 of 15 AMLs, the micro-balloon catheter could be advanced to the feeding artery, and TAE was performed successfully. Thus, the technical success rate was 93%. Among these 14 AMLs of 11 patients, 13 AMLs of 10 patients could be followed and tumor shrinkage was confirmed in all. Thus, the clinical success rate was 100%. Four patients had mild symptoms after TAE; the minor complication rate was 33% (4/12), and the major complication rate was 0%. Conclusion TAE for renal AML using the micro-balloon catheter and mixture of ethanol and lipiodol appears to be effective and safe.</description><identifier>ISSN: 0174-1551</identifier><identifier>EISSN: 1432-086X</identifier><identifier>DOI: 10.1007/s00270-017-1731-0</identifier><identifier>PMID: 28685379</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Angiomyolipoma ; Angiomyolipoma - therapy ; Antineoplastic Agents - administration &amp; dosage ; Balloon catheters ; Balloon treatment ; Cardiology ; Catheters ; Chemoembolization, Therapeutic - instrumentation ; Chemoembolization, Therapeutic - methods ; Child ; Complications ; Embolization ; Ethanol ; Ethanol - administration &amp; dosage ; Ethiodized Oil - administration &amp; dosage ; Feeding ; Female ; Females ; Humans ; Imaging ; Kidney Neoplasms - therapy ; Kidneys ; Male ; Males ; Medical instruments ; Medical records ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Nuclear Medicine ; Patients ; Radiology ; Retrospective Studies ; Success ; Technical Note ; Treatment Outcome ; Ultrasound ; Young Adult</subject><ispartof>Cardiovascular and interventional radiology, 2017-12, Vol.40 (12), p.1933-1939</ispartof><rights>Springer Science+Business Media, LLC and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2017</rights><rights>CardioVascular and Interventional Radiology is a copyright of Springer, 2017.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-75f3036e5d4472381d98f95f16018dbc9afd6640524b0f982044dfb094e2243a3</citedby><cites>FETCH-LOGICAL-c438t-75f3036e5d4472381d98f95f16018dbc9afd6640524b0f982044dfb094e2243a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28685379$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sawada, Yusuke</creatorcontrib><creatorcontrib>Shimohira, Masashi</creatorcontrib><creatorcontrib>Hashizume, Takuya</creatorcontrib><creatorcontrib>Sobue, Ryoji</creatorcontrib><creatorcontrib>Mori, Soichiro</creatorcontrib><creatorcontrib>Nakagawa, Motoo</creatorcontrib><creatorcontrib>Ozawa, Yoshiyuki</creatorcontrib><creatorcontrib>Naiki, Taku</creatorcontrib><creatorcontrib>Nagai, Takashi</creatorcontrib><creatorcontrib>Yasui, Takahiro</creatorcontrib><creatorcontrib>Shibamoto, Yuta</creatorcontrib><title>Transcatheter Arterial Embolization for Renal Angiomyolipoma Using a Micro-balloon Catheter and a Mixture of Ethanol and Lipiodol</title><title>Cardiovascular and interventional radiology</title><addtitle>Cardiovasc Intervent Radiol</addtitle><addtitle>Cardiovasc Intervent Radiol</addtitle><description>Purpose To evaluate the efficacy and safety of transcatheter arterial embolization (TAE) for renal angiomyolipoma (AML) using a micro-balloon catheter and a mixture of ethanol and lipiodol. Materials and Methods Twelve consecutive patients with 15 AMLs, 9 females and 3 males, with a median age of 44 years (range, 11–81), underwent this procedure between 2011 and 2016. In all procedures, a micro-balloon catheter was advanced to the feeding artery of the AML and TAE was performed with a mixture of ethanol and lipiodol under balloon inflation. We reviewed medical records and images, and evaluated the technical success rate, clinical success rate, and complications. Technical success was defined as completion of TAE using the micro-balloon catheter and the mixture of ethanol and lipiodol. Clinical success was defined as reduction of tumor size on CT, which was performed before and after TAE. Results In 14 of 15 AMLs, the micro-balloon catheter could be advanced to the feeding artery, and TAE was performed successfully. Thus, the technical success rate was 93%. Among these 14 AMLs of 11 patients, 13 AMLs of 10 patients could be followed and tumor shrinkage was confirmed in all. Thus, the clinical success rate was 100%. Four patients had mild symptoms after TAE; the minor complication rate was 33% (4/12), and the major complication rate was 0%. Conclusion TAE for renal AML using the micro-balloon catheter and mixture of ethanol and lipiodol appears to be effective and safe.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Angiomyolipoma</subject><subject>Angiomyolipoma - therapy</subject><subject>Antineoplastic Agents - administration &amp; dosage</subject><subject>Balloon catheters</subject><subject>Balloon treatment</subject><subject>Cardiology</subject><subject>Catheters</subject><subject>Chemoembolization, Therapeutic - instrumentation</subject><subject>Chemoembolization, Therapeutic - methods</subject><subject>Child</subject><subject>Complications</subject><subject>Embolization</subject><subject>Ethanol</subject><subject>Ethanol - administration &amp; dosage</subject><subject>Ethiodized Oil - administration &amp; dosage</subject><subject>Feeding</subject><subject>Female</subject><subject>Females</subject><subject>Humans</subject><subject>Imaging</subject><subject>Kidney Neoplasms - therapy</subject><subject>Kidneys</subject><subject>Male</subject><subject>Males</subject><subject>Medical instruments</subject><subject>Medical records</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Nuclear Medicine</subject><subject>Patients</subject><subject>Radiology</subject><subject>Retrospective Studies</subject><subject>Success</subject><subject>Technical Note</subject><subject>Treatment Outcome</subject><subject>Ultrasound</subject><subject>Young Adult</subject><issn>0174-1551</issn><issn>1432-086X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp1kU9rFDEYxoModq1-AC8S8OIl-ubfTOa4LOsfWBGkBW8hM5NsUzLJmsyA9dZv3my3FRG8JJDnl1948yD0msJ7CtB-KACsBQK0JbTllMATtKKCMwKq-fEUrWogCJWSnqEXpVwDUKmYfI7OmGqU5G23QrcX2cQymPnKzjbjda6rNwFvpz4F_9vMPkXsUsbfbazH67j3abqp0SFNBl8WH_fY4K9-yIn0JoRU8c2jzcTxPvw1L9ni5PB2vjIxhftg5w8-jSm8RM-cCcW-etjP0eXH7cXmM9l9-_Rls96RQXA1k1Y6DryxchSiZVzRsVOuk442QNXYD51xY9MIkEz04DrFQIjR9dAJy5jghp-jdyfvIaefiy2znnwZbAgm2rQUTbv6h43gABV9-w96nZZc5z9SUgrKODSVoieqzl5Ktk4fsp9MvtEU9LEffepH1xr0sR99NL95MC_9ZMc_Nx4LqQA7AaVGcW_zX0__13oHqFaajg</recordid><startdate>20171201</startdate><enddate>20171201</enddate><creator>Sawada, Yusuke</creator><creator>Shimohira, Masashi</creator><creator>Hashizume, Takuya</creator><creator>Sobue, Ryoji</creator><creator>Mori, Soichiro</creator><creator>Nakagawa, Motoo</creator><creator>Ozawa, Yoshiyuki</creator><creator>Naiki, Taku</creator><creator>Nagai, Takashi</creator><creator>Yasui, Takahiro</creator><creator>Shibamoto, Yuta</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20171201</creationdate><title>Transcatheter Arterial Embolization for Renal Angiomyolipoma Using a Micro-balloon Catheter and a Mixture of Ethanol and Lipiodol</title><author>Sawada, Yusuke ; Shimohira, Masashi ; Hashizume, Takuya ; Sobue, Ryoji ; Mori, Soichiro ; Nakagawa, Motoo ; Ozawa, Yoshiyuki ; Naiki, Taku ; Nagai, Takashi ; Yasui, Takahiro ; Shibamoto, Yuta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-75f3036e5d4472381d98f95f16018dbc9afd6640524b0f982044dfb094e2243a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Angiomyolipoma</topic><topic>Angiomyolipoma - therapy</topic><topic>Antineoplastic Agents - administration &amp; dosage</topic><topic>Balloon catheters</topic><topic>Balloon treatment</topic><topic>Cardiology</topic><topic>Catheters</topic><topic>Chemoembolization, Therapeutic - instrumentation</topic><topic>Chemoembolization, Therapeutic - methods</topic><topic>Child</topic><topic>Complications</topic><topic>Embolization</topic><topic>Ethanol</topic><topic>Ethanol - administration &amp; dosage</topic><topic>Ethiodized Oil - administration &amp; dosage</topic><topic>Feeding</topic><topic>Female</topic><topic>Females</topic><topic>Humans</topic><topic>Imaging</topic><topic>Kidney Neoplasms - therapy</topic><topic>Kidneys</topic><topic>Male</topic><topic>Males</topic><topic>Medical instruments</topic><topic>Medical records</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Nuclear Medicine</topic><topic>Patients</topic><topic>Radiology</topic><topic>Retrospective Studies</topic><topic>Success</topic><topic>Technical Note</topic><topic>Treatment Outcome</topic><topic>Ultrasound</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sawada, Yusuke</creatorcontrib><creatorcontrib>Shimohira, Masashi</creatorcontrib><creatorcontrib>Hashizume, Takuya</creatorcontrib><creatorcontrib>Sobue, Ryoji</creatorcontrib><creatorcontrib>Mori, Soichiro</creatorcontrib><creatorcontrib>Nakagawa, Motoo</creatorcontrib><creatorcontrib>Ozawa, Yoshiyuki</creatorcontrib><creatorcontrib>Naiki, Taku</creatorcontrib><creatorcontrib>Nagai, Takashi</creatorcontrib><creatorcontrib>Yasui, Takahiro</creatorcontrib><creatorcontrib>Shibamoto, Yuta</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database (ProQuest)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Cardiovascular and interventional radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sawada, Yusuke</au><au>Shimohira, Masashi</au><au>Hashizume, Takuya</au><au>Sobue, Ryoji</au><au>Mori, Soichiro</au><au>Nakagawa, Motoo</au><au>Ozawa, Yoshiyuki</au><au>Naiki, Taku</au><au>Nagai, Takashi</au><au>Yasui, Takahiro</au><au>Shibamoto, Yuta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transcatheter Arterial Embolization for Renal Angiomyolipoma Using a Micro-balloon Catheter and a Mixture of Ethanol and Lipiodol</atitle><jtitle>Cardiovascular and interventional radiology</jtitle><stitle>Cardiovasc Intervent Radiol</stitle><addtitle>Cardiovasc Intervent Radiol</addtitle><date>2017-12-01</date><risdate>2017</risdate><volume>40</volume><issue>12</issue><spage>1933</spage><epage>1939</epage><pages>1933-1939</pages><issn>0174-1551</issn><eissn>1432-086X</eissn><abstract>Purpose To evaluate the efficacy and safety of transcatheter arterial embolization (TAE) for renal angiomyolipoma (AML) using a micro-balloon catheter and a mixture of ethanol and lipiodol. Materials and Methods Twelve consecutive patients with 15 AMLs, 9 females and 3 males, with a median age of 44 years (range, 11–81), underwent this procedure between 2011 and 2016. In all procedures, a micro-balloon catheter was advanced to the feeding artery of the AML and TAE was performed with a mixture of ethanol and lipiodol under balloon inflation. We reviewed medical records and images, and evaluated the technical success rate, clinical success rate, and complications. Technical success was defined as completion of TAE using the micro-balloon catheter and the mixture of ethanol and lipiodol. Clinical success was defined as reduction of tumor size on CT, which was performed before and after TAE. Results In 14 of 15 AMLs, the micro-balloon catheter could be advanced to the feeding artery, and TAE was performed successfully. Thus, the technical success rate was 93%. Among these 14 AMLs of 11 patients, 13 AMLs of 10 patients could be followed and tumor shrinkage was confirmed in all. Thus, the clinical success rate was 100%. Four patients had mild symptoms after TAE; the minor complication rate was 33% (4/12), and the major complication rate was 0%. Conclusion TAE for renal AML using the micro-balloon catheter and mixture of ethanol and lipiodol appears to be effective and safe.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>28685379</pmid><doi>10.1007/s00270-017-1731-0</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0174-1551
ispartof Cardiovascular and interventional radiology, 2017-12, Vol.40 (12), p.1933-1939
issn 0174-1551
1432-086X
language eng
recordid cdi_proquest_miscellaneous_1917364300
source Springer Link
subjects Adolescent
Adult
Aged
Aged, 80 and over
Angiomyolipoma
Angiomyolipoma - therapy
Antineoplastic Agents - administration & dosage
Balloon catheters
Balloon treatment
Cardiology
Catheters
Chemoembolization, Therapeutic - instrumentation
Chemoembolization, Therapeutic - methods
Child
Complications
Embolization
Ethanol
Ethanol - administration & dosage
Ethiodized Oil - administration & dosage
Feeding
Female
Females
Humans
Imaging
Kidney Neoplasms - therapy
Kidneys
Male
Males
Medical instruments
Medical records
Medicine
Medicine & Public Health
Middle Aged
Nuclear Medicine
Patients
Radiology
Retrospective Studies
Success
Technical Note
Treatment Outcome
Ultrasound
Young Adult
title Transcatheter Arterial Embolization for Renal Angiomyolipoma Using a Micro-balloon Catheter and a Mixture of Ethanol and Lipiodol
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T07%3A21%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transcatheter%20Arterial%20Embolization%20for%20Renal%20Angiomyolipoma%20Using%20a%20Micro-balloon%20Catheter%20and%20a%20Mixture%20of%20Ethanol%20and%20Lipiodol&rft.jtitle=Cardiovascular%20and%20interventional%20radiology&rft.au=Sawada,%20Yusuke&rft.date=2017-12-01&rft.volume=40&rft.issue=12&rft.spage=1933&rft.epage=1939&rft.pages=1933-1939&rft.issn=0174-1551&rft.eissn=1432-086X&rft_id=info:doi/10.1007/s00270-017-1731-0&rft_dat=%3Cproquest_cross%3E1955412306%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c438t-75f3036e5d4472381d98f95f16018dbc9afd6640524b0f982044dfb094e2243a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1955412306&rft_id=info:pmid/28685379&rfr_iscdi=true